Literature DB >> 16397134

Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL).

Shino Hanabuchi1, Norihiko Watanabe, Yi-Hong Wang, Yui-Hsi Wang, Tomoki Ito, Joanne Shaw, Wei Cao, F Xiao-Feng Qin, Yong-Jun Liu.   

Abstract

Plasmacytoid dendritic cell precursors (pDCs) are professional type I interferon-producing cells, a critical cell type in regulating innate and adaptive immune responses. By microarray gene expression analysis, we found that pDCs activated by virus or CpG-ODN preferentially express the ligand for the glucocorticoid-induced tumor necrosis factor receptor (GITRL), which was confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR) and flow cytometry analysis. Using the same approaches, we found GITR is expressed by activated natural killer (NK) cells and T cells. We show that pDCs activated by CpG-ODN promote NK cell cytotoxicity and interferon (IFN)-gamma production through type I IFNs and GITRL. Using a GITRL-transfected cell line, we further demonstrate that GITRL promotes NK cell cytotoxicity and IFN-gamma production in synergy with interleukin-2 (IL-2), IFN-alpha, and NKG2D triggering. We also demonstrated that pDCs localized in close contact to NK cells in T-cell areas of the tonsils, and a subpopulation of the pDCs expressed GITRL. This study reveals a novel function of GITR/GITRL in pDC-mediated coactivation of NK cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16397134     DOI: 10.1182/blood-2005-08-3419

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.

Authors:  C Ritchlin; F Tausk
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

2.  Glucocorticoid-induced tumour necrosis factor receptor family-related receptor signalling exacerbates hapten-induced colitis by CD4+ T cells.

Authors:  Sun K Lee; Beom K Choi; Young H Kim; Woo J Kang; Kwang H Kim; Shimon Sakaguchi; Jae H Suh; Tae Y Kim; Byoung S Kwon
Journal:  Immunology       Date:  2006-12       Impact factor: 7.397

3.  Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70.

Authors:  Joanne Shaw; Yui-Hsi Wang; Tomoki Ito; Kazuhiko Arima; Yong-Jun Liu
Journal:  Blood       Date:  2010-02-04       Impact factor: 22.113

Review 4.  Mechanisms of NK cell activation: CD4(+) T cells enter the scene.

Authors:  Franck Bihl; Claire Germain; Carmelo Luci; Veronique M Braud
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

Review 5.  Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals.

Authors:  Rosa Barreira da Silva; Christian Münz
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

6.  Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells.

Authors:  David B Rosen; Wei Cao; Danielle T Avery; Stuart G Tangye; Yong-Jun Liu; J P Houchins; Lewis L Lanier
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

7.  Enhancement of T-cell-mediated anti-tumour immunity via the ectopically expressed glucocorticoid-induced tumour necrosis factor receptor-related receptor ligand (GITRL) on tumours.

Authors:  Jinhua Piao; Yosuke Kamimura; Hideyuki Iwai; Yujia Cao; Keisuke Kikuchi; Masaaki Hashiguchi; Taro Masunaga; Hongsi Jiang; Kouichi Tamura; Shimon Sakaguchi; Miyuki Azuma
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

8.  Role of a histamine 4 receptor as an anti-inflammatory target in carrageenan-induced pleurisy in mice.

Authors:  Sheikh Fayaz Ahmad; Khairy M A Zoheir; Hala E Abdel-Hamied; Ibrahim Alrashidi; Sabry M Attia; Saleh A Bakheet; Abdelkader E Ashour; Adel R A Abd-Allah
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

Review 9.  Progress and challenges in the vaccine-based treatment of head and neck cancers.

Authors:  Aldo Venuti
Journal:  J Exp Clin Cancer Res       Date:  2009-05-27

10.  Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target.

Authors:  Sylvaine You; Lynn Poulton; Steve Cobbold; Chih-Pin Liu; Michael Rosenzweig; Douglas Ringler; Wen-Hui Lee; Berta Segovia; Jean-François Bach; Herman Waldmann; Lucienne Chatenoud
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.